|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.04 AUD | +2.56% |
|
0.00% | -45.95% |
| 08/05 | Radiopharm Theranostics to be Featured in Healthcare Events Hosted by B. Riley Securities | MT |
| 29/02 | Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study | MT |
Radiopharm Theranostics Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was AUD 0.292359 million. Net loss was AUD 34.61 million compared to AUD 30.42 million a year ago.
Basic loss per share from continuing operations was AUD 0.1132 compared to AUD 0.1678 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -45.95% | 11.93M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
RADIOPHARM THERANOSTICS LIMITED 
